TLX: Telix Pharmaceuticals Limited American Depositary Shares Stocks News on May 9, 2025

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

TLX

PR Newswire

2 days ago

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

TLX

PR Newswire

11 days ago

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

TLX

GlobeNewswire

11 days ago

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

Telix Reports US$186M Q1 Revenue, Up 62% YOY

TLX

GlobeNewswire

17 days ago

Telix Reports US$186M Q1 Revenue, Up 62% YOY

Telix Pharmaceuticals Touts Encouraging Data From Investigational Radiation Therapy In Relapsed Brain Cancer Patients

TLX

Benzinga

23 days ago

Telix Pharmaceuticals Touts Encouraging Data From Investigational Radiation Therapy In Relapsed Brain Cancer Patients

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate

TLX

PR Newswire

24 days ago

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate

All You Need to Know About Telix Pharmaceuticals Limited (TLX) Rating Upgrade to Buy

TLX

Zacks

25 days ago

All You Need to Know About Telix Pharmaceuticals Limited (TLX) Rating Upgrade to Buy

Telix Announces Cardinal Health for Gozellix Commercial Distribution

TLX

GlobeNewswire

a month ago

Telix Announces Cardinal Health for Gozellix Commercial Distribution

Telix Appoints Paul Schaffer as Chief Technology Officer

TLX

GlobeNewswire

a month ago

Telix Appoints Paul Schaffer as Chief Technology Officer

Anne Whitaker Appointed as Non-Executive Director

TLX

GlobeNewswire

a month ago

Anne Whitaker Appointed as Non-Executive Director

Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma

TLX

GlobeNewswire

a month ago

Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma

ARTMS Drug Master File for Gallium Production Technology Referenced with Telix’s Gozellix®

TLX

GlobeNewswire

a month ago

ARTMS Drug Master File for Gallium Production Technology Referenced with Telix’s Gozellix®

FDA Approves New Prostate Cancer Imaging Agent Gozellix®

TLX

GlobeNewswire

2 months ago

FDA Approves New Prostate Cancer Imaging Agent Gozellix®

Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America

TLX

PR Newswire

2 months ago

Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America

Telix Adds Lead-212 Isotope Production Capability

TLX

PR Newswire

2 months ago

Telix Adds Lead-212 Isotope Production Capability

Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum

TLX

PR Newswire

2 months ago

Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum

FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review

TLX

PR Newswire

2 months ago

FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review

Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami

TLX

GlobeNewswire

2 months ago

Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami

Telix Pharmaceuticals Limited (TLX) Upgraded to Buy: What Does It Mean for the Stock?

TLX

Zacks

2 months ago

Telix Pharmaceuticals Limited (TLX) Upgraded to Buy: What Does It Mean for the Stock?

TLX

GuruFocus.com

3 months ago

Telix Pharmaceuticals Ltd (TLPPF) (FY 2024) Earnings Call Highlights: Record Revenue Growth and ...

Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion

TLX

PR Newswire

3 months ago

Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion

Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)

TLX

GlobeNewswire

3 months ago

Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)

Illuccix® Approved in the United Kingdom

TLX

GlobeNewswire

3 months ago

Illuccix® Approved in the United Kingdom

Is Telix Pharmaceuticals Limited (TLX) the Best Long Term ASX Stock to Buy Now?

TLX

Insider Monkey

3 months ago

Is Telix Pharmaceuticals Limited (TLX) the Best Long Term ASX Stock to Buy Now?

Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

TLX

PR Newswire

3 months ago

Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

Telix Completes Acquisition of RLS (USA) Inc.

TLX

GlobeNewswire

3 months ago

Telix Completes Acquisition of RLS (USA) Inc.

ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery

TLX

PR Newswire

4 months ago

ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery

TLX

PR Newswire

4 months ago

Illuccix® Receives European Approval

Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference

TLX

PR Newswire

4 months ago

Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference

Telix Exceeds FY24 Guidance with US$142M Q4 Revenue

TLX

PR Newswire

4 months ago

Telix Exceeds FY24 Guidance with US$142M Q4 Revenue

Scintimun® Commercialization Partnership with Curium Pharma

TLX

PR Newswire

4 months ago

Scintimun® Commercialization Partnership with Curium Pharma

Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

TLX

PR Newswire

4 months ago

Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports

TLX

PR Newswire

4 months ago

NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

TLX

PR Newswire

4 months ago

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

TLX

GlobeNewswire

4 months ago

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete

TLX

GlobeNewswire

5 months ago

Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete

First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients

TLX

PR Newswire

5 months ago

Latest Telix Pharmaceuticals Limited American Depositary Shares (TLX) News on May 9, 2025

Telix FAP-targeting Therapeutic Published in Thyroid Journal: Demonstrates Encouraging Efficacy

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

Telix Reports US$186M Q1 Revenue, Up 62% YOY

Telix Pharmaceuticals Touts Encouraging Data From Investigational Radiation Therapy In Relapsed Brain Cancer Patients

IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate

All You Need to Know About Telix Pharmaceuticals Limited (TLX) Rating Upgrade to Buy

Telix Announces Cardinal Health for Gozellix Commercial Distribution

Telix Appoints Paul Schaffer as Chief Technology Officer

Anne Whitaker Appointed as Non-Executive Director

Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma

ARTMS Drug Master File for Gallium Production Technology Referenced with Telix’s Gozellix®

FDA Approves New Prostate Cancer Imaging Agent Gozellix®

Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America

Telix Adds Lead-212 Isotope Production Capability

Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum

FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review

Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami

Telix Pharmaceuticals Limited (TLX) Upgraded to Buy: What Does It Mean for the Stock?

Telix Pharmaceuticals Ltd (TLPPF) (FY 2024) Earnings Call Highlights: Record Revenue Growth and ...

Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion

Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)

Illuccix® Approved in the United Kingdom

Is Telix Pharmaceuticals Limited (TLX) the Best Long Term ASX Stock to Buy Now?

Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

Telix Completes Acquisition of RLS (USA) Inc.

ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery

Illuccix® Receives European Approval

Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference

Telix Exceeds FY24 Guidance with US$142M Q4 Revenue

Scintimun® Commercialization Partnership with Curium Pharma

Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete

First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients

Share on Social Networks: